Drug Search Results
More Filters [+]

Enrofloxacin

Alternative Names: enrofloxacin
Latest Update: 2024-05-13
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: DNA Gyrase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Inhalant

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Brazil | Dominican Republic | Hong Kong | India | Malaysia | Norway | Pakistan | Poland | South Africa

Approved Indications: None

Known Adverse Events: None

Company: Fraunhofer Institut
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Enrofloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EnroHuman

N/A

Completed

Healthy Volunteers

2018-06-04

Recent News Events